EDTA Chelation Therapy: Treatment of Peripheral Arterial Occlusion, An Alternative to Amputation

Back to Chelation Therapy India
EDTA Chelation Therapy: Treatment of Peripheral Arterial Occlusion, An Alternative to Amputation

H. Richard Casdorph, MD, Ph.D. and Charles H. Farr, MD, Ph.D.
Dr. H. Richard Casdorph is currently Assistant Clinical Professor of Medicine at the University of California Medical School, Irvine, California. He practices internal medicine and specializes in the treatment of cardiovascular disease at Long Beach, California. He received his training in cardiovascular diseases at the Mayo Clinic and received his Ph.D. degree in Medicine from the University of Minnesota. More recently he has taught at UCLA Medical School and has been Chief of Medicine at Long Beach Community Hospital. Dr. Charles H. Farr is Chairman of the American Board of Chelation Therapy and Diplomate in Chelation Therapy of the American Academy of Medical Preventics. He is currently in private practice in Oklahoma City, Oklahoma.

ABSTRACT: Four patients are presented, each of whom represents end stage occlusive peripheral arterial disease with gangrene of the involved extremity. These patients had exhausted all traditional forms of therapy and they had all been referred for surgical amputation. Instead of surgery, intravenous EDTA chelation therapy was instituted with complete success in each case. These gangrenous extremities all healed and were saved from amputation. Long-term follow-up, extending for more than a year, indicates that all four patients are continuing to do well, with their previously gangrenous extremities intact and pain free. Adjunctive therapies included vitamin and mineral supplementation and, in two cases, hyperbaric oxygen therapy (HBO).

Journal of Advancement in Medicine, Volume 2, Numbers 1/2, Spring/Summer 1989
For the full-text study, go to your nearest medical library or order

Back to Chelation Therapy India